Region‐specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma

Genes, Chromosomes and Cancer

Volumn 12, Issue 4, 1995, Pages 277-282

  Ritland, Steven R ^a   Ganju, Vinod ^b   Jenkins, Dr Robert B ^a  

^a MAYO CLINIC   (United States)

^b GEELONG HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; CHILD; CHROMOSOME 19; CHROMOSOME 19Q; CHROMOSOME MARKER; GENE DELETION; GENE LOCATION; GENE MUTATION; GLIOMA; HETEROZYGOTE DETECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 19; COMPARATIVE STUDY; CONFIDENCE INTERVALS; GENETIC MARKERS; GLIOMA; HUMAN; INFANT; MIDDLE AGE; OLIGODENDROGLIOMA; POLYMORPHISM (GENETICS); SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028954148     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.2870120407     Document Type: Article

References (33)

1. Oncogenes: Cause or consequence in the development of glial tumors
2. Specific chromosomal abnormalities in malignant human gliomas
3. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
4. Human epithelial ovarian cancer allelotype
5. Gene and chromosomal alterations associated with the development of human gliomas
6. Grading of astrocytomas: A simple and reproducible method
7. Identification of a chromosome 18q gene that is altered in colorectal cancers
8. p53 mutations in human malignant gliomas: Comparison of loss of heterozygosity with mutation frequency
9. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
10. Biological response modifier therapies for patients with malignant gliomas
11. The treatment of oligodendrogliomas and mixed oligodendrogliomas‐astrocytomas with PCV chemotherapy
12. Lack of expression of tumor‐suppressor genes in human malignant glioma cell lines
13. Identification and characterization of the familial adenomatous polyposis coli gene
14. The 1993–94 Genethon human genetic linkage map
15. Chromosome 9 deletion mapping reveals interferon alpha and interferon beta‐1 gene deletions in human glial tumors
16. A cytogenetic study of 53 human gliomas
17. A cell cycle regulator potentially involved in genesis of many tumor types
18. Mutations in the p53 gene occur in diverse human tumor types
19. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligoastrocytomas
20. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas
21. Loss of heterozygosity for 10 loci in human gliomas
22. Cytogenetics and molecular genetics of central nervous system tumors
23. Second International Workshop on Human Chromosome 19 Mapping
24. Oligodendrogliomas: The Mayo Clinic experience
25. Microsatellite instability in cancer of the proximal colon
26. A novel moesin‐, ezrin‐, radixin‐like gene is a candidate for the neurofibromatosis 2 tumor suppressor
27. Genetic alterations during colorectal tumor development
28. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma
29. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas
30. Loci associated with malignant progression in astrocytomas: A candidate on chromosome 19q
31. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification